Home » Topics » Regulatory » Patents

Patents
RSS

Medshine Discovery patents IRAK4 and BTK inhibitors

July 19, 2022

Merck & Co. synthesizes orexin OX2 receptor agonists

July 18, 2022

Pfizer describes new IL-2 production inhibitors

July 18, 2022

Janssen Pharmaceutica presents new Mcl-1 inhibitors

July 18, 2022

Novartis divulges new cGAS inhibitors

July 18, 2022

Sunshine Lake Pharma patents new chymotrypsin inhibitors

July 18, 2022

BioWorld MedTech Patent Highlights: Week 27

From Current Patent Gazette

July 15, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Amgen describes new PRMT5 inhibitors

July 15, 2022

Zydus Lifesciences identifies new PCSK9 inhibitors

July 15, 2022

GlaxoSmithKline synthesizes new Nav1.8 channel blockers

July 15, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...